Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
100%
Non-melanoma Skin Cancer
100%
P14ARF
100%
P16INK4a
50%
P53 Gene
50%
Exon 1
50%
Tumor
33%
Genetic Abnormalities
33%
TP53 mutation
33%
CDKN2A Gene
33%
P53 Pathway
33%
Exon 2
33%
Loss of Expression
33%
Human Melanoma
16%
Squamous Cell Carcinoma (SqCC)
16%
Actinic Keratosis
16%
Basal Cell Carcinoma
16%
Immunostaining
16%
Polymerase Chain Reaction
16%
Retinoblastoma
16%
Protein Expression
16%
Tumor Suppressor
16%
Cancer Cells
16%
Human Chromosomes
16%
Immunohistochemical Analysis
16%
Genetic Modification
16%
Tumor Progression
16%
Genomic DNA (gDNA)
16%
Gene Loss
16%
P53 Tumor Suppressor Gene
16%
Tumor Suppressor Activity
16%
Tumor Protein p53 (TP53)
16%
Strongly Positive
16%
Active Role
16%
Chromosome 9p21
16%
Mutated Genes
16%
Retinoblastoma Tumor Suppressor
16%
Signature mutations
16%
Ultraviolet-B (UV-B)
16%
Homozygous Deletion
16%
Retinoblastoma Pathway
16%
Biochemistry, Genetics and Molecular Biology
P14arf
100%
Cyclin Dependent Kinase Inhibitor 2A
100%
P53
58%
Exon
25%
Protein P53
25%
Retinoblastoma
25%
Genetics
16%
Tumor Suppressor Protein
16%
Genomics
8%
Cancer Cell
8%
Gene Mutation
8%
Protein Expression
8%
Human Chromosome
8%
Immunostaining
8%
Polymerase Chain Reaction
8%
Mutated Genes
8%
Gene Loss
8%
Tumor Progression
8%
Tumor Suppressor Gene
8%